Collectively, these results indicate that QDYXD reduces M1 macrophage polarization and inhibits the HIF-1 signaling pathway by downregulating PGK1, LDHA, and HIF1A expression, thereby improving cardiac function in DCM. The gene discussed is HIF1A; the disease is familial dilated cardiomyopathy.